We recently reported that LiCl, which inhibits GSK3, administration was able to re-sensitize chemoresistant colon cancer cells to 5FU chemotherapeutic action, in vitro and in vivo [19] and we used this model of chemoresistance to investigate a possible involvement of TGF-β pathway in this phenomenon. Here, TGFB1 is linked to colonic neoplasm.